Stay updated on Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updated revision to v3.0.2 and removed the Back to Top control; no substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-14T00:20:15.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-06T21:22:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has added significant content related to plasma cell myeloma, including a new facility name and location, as well as a list of relevant publications from PubMed. However, it has removed various location-related terms and specific drug classifications.
    Difference
    7%
    Check dated 2025-08-30T15:57:25.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T12:47:55.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T08:09:02.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-02T04:15:57.000Z thumbnail image

Stay in the know with updates to Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page.